Banque de Luxembourg Investments (BLI)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Banque de Luxembourg Investments (BLI)'s BMY Position: Q1 2026 in Review
Banque de Luxembourg Investments (BLI) held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 247,000 shares worth $13.2M. The position accounts for 0.39% of the portfolio, ranked #68.
Banque de Luxembourg Investments (BLI) first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.8M in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Banque de Luxembourg Investments (BLI) held 247,000 shares of Bristol-Myers Squibb worth $13.2M as of Q1 2026.
- Banque de Luxembourg Investments (BLI) left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.39% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #68 holding.
- Banque de Luxembourg Investments (BLI) first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Banque de Luxembourg Investments (BLI)'s Bristol-Myers Squibb position peaked at $14.8M in Q1 2025.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.